Last reviewed · How we verify
NCT02073175
Development of Dietary Supplements for Mood Symptoms in Postpartum
Phase 2 trial testing Motherwell in Postpartum Blues in 28 participants. Completed in 1 April 2016.
1 April 2016
Quick facts
| Lead sponsor | Centre for Addiction and Mental Health |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 28 |
| Start date | 1 February 2014 |
| Primary completion | 1 April 2016 |
| Estimated completion | 1 April 2016 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Motherwell — full drug profile →
Conditions studied
- Postpartum Blues — all drugs for Postpartum Blues →
- Healthy — all drugs for Healthy →
Sponsor
Centre for Addiction and Mental Health — full company profile →
Who can join
Adults 18 to 45, female only, with Postpartum Blues or Healthy. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Change in Visual Analog Scale (VAS)
Time frame: Assessment will be done on day-5 postpartum or within the first 18 months postpartum (depending on which group subject belongs to). On the assessment day, the VAS will be administered before and after sad mood indcution and compared
VAS uses a 10-cm scale for participants to indicate the extent to which each of them feel happy or sad. The change in VAS before versus after sad mood induction is the change score in VAS. The change score on the day with active dietary supplement is compare to the change score of the subjects who have not received any supplement and have been recently recruited
Sponsor's own description
The purpose of this study is to determine whether a dietary supplement (DS) is effective in protecting against sad mood in postpartum.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Selective dietary supplementation in early postpartum is associated with high resilience against depressed mood.
Dowlati Y, Ravindran AV, Segal ZV, Stewart DE, et al · · 2017 · cited 24× · PMID 28289215 · DOI 10.1073/pnas.1611965114
Verify or expand the search:
- PubMed search for NCT02073175
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Motherwell
Trials testing the same drug.
- NCT03296956 — A Dietary Supplement for Mood Symptoms in Early Postpartum: A Double Blind Randomized Placebo Controlled Trial · NA · completed
Other Centre for Addiction and Mental Health trials
Trials by the same sponsor.
- NCT07211438 — Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression · Phase 2 · not yet recruiting
- NCT07146633 — Efficacy of an EMDR App for PTSD and SUD · NA · recruiting
- NCT07228923 — Development and Evaluation of a Theory and Evidence-based Intervention to Reduce Hazardous Alcohol Consumption Among Tre · NA · not yet recruiting
- NCT07105449 — THC Titration of High-Potency Cannabis Concentrates · NA · not yet recruiting
- NCT06928935 — Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for Psychosis · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02073175 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre for Addiction and Mental Health
- Last refreshed: 11 April 2016
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02073175.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing